Pseudohyperkalemia in myotonic dystrophy type 1: A case report

被引:0
|
作者
Hatano, Taku [1 ,4 ]
Uchida, Toyoyoshi [2 ]
Hayashi, Hidemori [3 ]
Hattori, Nobutaka [1 ]
机构
[1] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo, Japan
[3] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Biol & Med, Tokyo, Japan
[4] Juntendo Univ, Grad Sch Med, Dept Neurol, 2-1-1,Hongo,Bunkyo Ku, Tokyo 1138421, Japan
来源
NEUROLOGY AND CLINICAL NEUROSCIENCE | 2024年 / 12卷 / 05期
基金
日本学术振兴会;
关键词
electrolyte imbalance; MDPK; myotonic dystrophy; psuedohyperkalemia;
D O I
10.1111/ncn3.12812
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myotonic dystrophy type 1 (DM1) is an autosomal dominant familial muscular dystrophy caused by abnormal CTG repeat expansion in the myotonic dystrophy protein kinase (DMPK) gene. The cardinal features of DM1 patients are muscular weakness, myotonia, and arrhythmia. DM1 patients with electrolyte imbalance caused by endocrinological alterations have also been reported. Herein, we report a female patient with DM1 and hyperkalemia, which fluctuated depending on the blood collection methods. We revealed that cold stimulation of red blood cells was associated with hyperkalemia, whereas blood examination immediately after collection showed normal potassium levels. She was, therefore, diagnosed with pseudohyperkalemia. Several previous reports have described DM1 patients with pseudohyperkalemia, similar to ours. Neurologists should be aware that some patients with DM1 may have pseudohyperkalemia. Thus, consider retesting with prompt measurement after blood collection to rule out pseudohyperkalemia when a patient shows hyperkalemia. If confirmed, evaluate for DM1 as a potential differential diagnosis.
引用
收藏
页码:309 / 311
页数:3
相关论文
共 50 条
  • [21] Physical activity in myotonic dystrophy type 1
    Kirsten Lykke Knak
    Aisha Munawar Sheikh
    Nanna Witting
    John Vissing
    Journal of Neurology, 2020, 267 : 1679 - 1686
  • [22] THERAPEUTICS DEVELOPMENT IN MYOTONIC DYSTROPHY TYPE 1
    Foff, Erin Pennock
    Mahadevan, Mani S.
    MUSCLE & NERVE, 2011, 44 (02) : 160 - 169
  • [23] Targeting Myotonic Dystrophy Type 1 with Metformin
    Garcia-Puga, Mikel
    Saenz-Antonanzas, Ander
    Matheu, Ander
    Lopez de Munain, Adolfo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [24] Pathogenesis of myotonic dystrophy type 1.
    Magana, Jonathan J.
    Leyva-Garcia, Norberto
    Cisneros, Bulmaro
    GACETA MEDICA DE MEXICO, 2009, 145 (04): : 331 - 337
  • [25] Multiorgan manifestations in myotonic dystrophy type 1
    Varga David
    Pal Endre
    ORVOSI HETILAP, 2019, 160 (37) : 1447 - 1454
  • [26] Disease burden of myotonic dystrophy type 1
    Landfeldt, Erik
    Nikolenko, Nikoletta
    Jimenez-Moreno, Cecilia
    Cumming, Sarah
    Monckton, Darren G.
    Gorman, Grainne
    Turner, Chris
    Lochmueller, Hanns
    JOURNAL OF NEUROLOGY, 2019, 266 (04) : 998 - 1006
  • [27] Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy
    Logigian, Eric L.
    Ciafaloni, Emma
    Quinn, Christine
    Dilek, Nuran
    Pandya, Shree
    Moxley, Richard T., III
    Thornton, Charles A.
    MUSCLE & NERVE, 2007, 35 (04) : 479 - 485
  • [28] Perceived fatigue in myotonic dystrophy type 1: a case-control study
    Stefan Winblad
    Christopher Lindberg
    BMC Neurology, 19
  • [29] Perceived fatigue in myotonic dystrophy type 1: a case-control study
    Winblad, Stefan
    Lindberg, Christopher
    BMC NEUROLOGY, 2019, 19 (1)
  • [30] An Unusual Case of Hybrid Odontogenic Tumor in Type 1 Myotonic Dystrophy Patient
    Unni, Jiji V.
    Daryani, Deepak
    Uthkal, M. P.
    Mustafa, Shabil Mohamed
    INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2023, 13 (04) : 255 - 258